Furthermore, RNA decay assays demonstrated that IGF2BP3 inhibited MALAT1 decay rates, suggesting that IGF2BP3 stabilizes MALAT1 in HBV/HBx-expressing HCC cells (Fig. 4P). Here, MALAT1 is linked to hepatocellular carcinoma.